852-通过逆流键工程攻克肿瘤自抗原T细胞耐受 episode artwork

EPISODE · Apr 25, 2026 · 18 MIN

852-通过逆流键工程攻克肿瘤自抗原T细胞耐受

from 聊聊Sci

这项研究介绍了一种名为“TCR涡轮增压”的新型免疫工程平台,旨在通过捕捉键(catch-bond)工程技术增强T细胞对癌症的杀伤力。研究人员针对前列腺癌中的前列腺酸性磷酸酶(PAP),成功改良了原本反应微弱的天然T细胞受体。通过在受体特定区域引入关键的氨基酸突变,这种技术延长了受体与肿瘤抗原结合的有效时间,从而在不增加脱靶风险的前提下,显著提升了T细胞在体内的增殖能力和抗肿瘤活性。实验结果显示,这种经工程化改良的T细胞能更有效地清除肿瘤,并展现出更强的抵抗免疫疲劳的特性。该成果为开发更高效、更安全的TCR-T细胞疗法提供了一种基于生物物理机制的新策略。References: Chen X, Mao Z, Kolawole E M, et al. Overcoming T cell tolerance to tumor self-antigens through catch-bond engineering[J]. Science, 2026, 391(6791): eadx3162.前往小宇宙评论区与主播互动

Episode metadata supplied by the publisher feed · Published Apr 25, 2026

Embed this episode

Ready to play

852-通过逆流键工程攻克肿瘤自抗原T细胞耐受

0:00 18:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 聊聊Sci?

This episode is 18 minutes long.

When was this 聊聊Sci episode published?

This episode was published on April 25, 2026.

Can I download this 聊聊Sci episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!